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Abstract
Nutritional factors and infectious agents may contribute to paediatric growth deficits in low-
and middle-income countries; however, the contribution of enteric pathogens is only begin-
ning to be understood. We analysed the stool from children <5 years old from an open cohort,
cluster-randomised controlled trial of a point-of-collection water chlorinator in urban
Bangladesh. We compared the presence/absence of 15 enteric pathogens detected via multi-
plex, molecular methods in the stool with concurrent Z-scores/Z-score cut-offs (−2 standard
deviations (S.D.)) for height-for-age (HAZ/stunting), weight-for-age (WAZ/underweight) and
weight-for-height (WHZ/wasting), adjusted for sociodemographic and trial-related factors,
and measured caregiver-reported diarrhoea. Enteric pathogen prevalence in the stool was
high (88% had ≥1 enteric pathogen, most commonly Giardia spp. (40%), Salmonella enterica
(33%), enterotoxigenic E. coli (28%) and Shigella spp. (27%)) while reported 7-day diarrhoea
prevalence was 6%, suggesting high subclinical infection rates. Many children were stunted
(26%) or underweight (24%). Adjusted models suggested Giardia spp. detection was asso-
ciated with lower HAZ (−0.22 S.D., 95% CI −0.44 to 0.00; prevalence ratio for stunting:
1.39, 95% CI 0.94–2.06) and potentially lower WAZ. No pathogens were associated with
reported diarrhoea in adjusted models. Giardia spp. carriage may be associated with growth
faltering, but not diarrhoea, in this and similar low-income settings. Stool-based enteric
pathogen detection provides a direct indication of previous exposure that may be useful as
a broader endpoint of trials of environmental interventions.
Introduction
Almost 27% of the world’s preschool children are stunted (defined specifically as height-for-
age Z-scores ⩽2 standard deviations below the mean), with hundreds of millions more under-
weight (low weight-for-age) or wasted (low weight-for-height), especially in low- and
middle-income countries [1, 2]. Beyond the poor nutrition that characterises many diets in
these settings, the role of recurrent or persistent enteric infections in undernutrition, and espe-
cially linear growth faltering (defined as any low height-for-age), is incompletely understood
[3, 4]. These enteric infections may elicit inflammatory immune responses that can lead to
chronic gut inflammation, and subsequent morphological changes, reduced absorptive cap-
acity for nutrients and other sequelae [5]. This condition, termed environmental enteric dys-
function (EED), expands the scope of potential health impacts associated with enteric
infections to include subclinical infections that contribute to gut inflammation without the
presence of diarrhoea [6].
While the diarrhoeal disease affects more than 1.7 billion children worldwide each year [7],
the burden of enteric infections – inclusive of asymptomatic infections – is even larger, espe-
cially in young children [8–10]. A multisite cohort study of both non-diarrhoeal and diar-
rhoeal stool from children <2 years old – when impacts of environmental conditions on
linear growth, may be most important [11] – observed that more than two-thirds of the chil-
dren were shedding an enteric pathogen in the stool, indicative of current or previous infection
or asymptomatic carriage [9]. Notably, while about 77% of diarrhoeal stool was positive for ≥1
enteric pathogen, 65% of non-diarrhoeal stool was also positive across sites [9]. The prevalence
of bacterial, viral and protozoan infections varies by region and age range [8, 9], and thus
infection-related drivers of growth faltering may also vary, making
contextualisation of the local burden of enteric infection import-
ant [12].
Although environmental interventions focused on reducing
exposures to faecal pathogens – for example, improved water,
sanitation and hygiene (WASH) infrastructure – have typically
been evaluated by their effectiveness in reducing diarrhoea [13],
recognition of the potential impact of subclinical infections is
broadening the focus of such studies to target both symptomatic
and asymptomatic enteric infections [14]. By extension, the
impact of interventions on linear growth and other nutritional
outcomes is being measured. Two studies have already reported
significant effects of improved community-level sanitation on
linear growth in the absence of measurable effects on diarrhoea
[15, 16], but other major randomised-controlled trials have not
observed such outcomes [17–19]. The challenges and expenses
of discerning and interpreting the pathogen-specific biological
and environmental pathways through which EED acts [20] have
resulted in the limited analysis of pathogens and child growth.
However, recently-completed multisite studies may add to these
results in the near future [17, 18].
As WASH implementers strive to impact not only faecal patho-
gen exposures but also linear growth, it is important to understand
the roles and burdens (e.g. background circulation) of specific
pathogens. This importance is twofold: (1) enteric pathogens
may be aetiological agents of symptomatic illness with short-term
impacts; and perhaps more importantly, (2) those same enteric
pathogens may also be the cause of asymptomatic infection or
be commensally carried in the gut, resulting in longer-term
impacts [4]. Pathogen-specific approaches are likely not the long-
term solution to controlling enteric infections – many enteric
pathogens share transmission pathways and may be controlled
via system-level improvements in WASH infrastructure [21].
However, improved understanding of pathogen- and pathway-
specific contributions to poor nutrition in low-income settings
can inform intervention strategies, exposure measurement and
risk assessment [22]. Within the context of a cluster-randomised
controlled trial of an automated point-of-collection water chlorin-
ation device in urban Bangladesh [23], we conducted a sub-analysis
exploring associations between pathogen carriage, symptomatic
diarrhoea and anthropometric outcomes (height-for-age, weight-
for-age and weight-for-height) among children <5 years old to
identify potential pathogens of importance for these outcomes.
Results from this analysis can contribute to future efforts to under-
stand and mitigate these pathogens – regardless of symptoms –
with environmental interventions and highlight the importance
of subclinical infections in nutritional outcomes.
Methods
This analysis was nested within a previously described, cluster-
randomised controlled trial of a point-of-collection chlorinator
on self-reported diarrhoea in children in two urban and peri-
urban communities in and around Dhaka, Bangladesh
(NCT02606981) [23]. While this analysis is cross-sectional for
the specified outcomes in children in both intervention and con-
trol groups, the parent trial included data collection from an
open cohort of children <5 years old (enrolled for a baseline
(pre-intervention) evaluation between July and November
2015, and followed-up approximately every 2 months over
seven post-intervention rounds (rounds 1–7) from November
2015 to December 2016). Briefly, the parent trial was conducted
in two low-income neighbourhoods: Tongi, a community out-
side Dhaka, and Dhaka Uddan, a community within Dhaka
city. Compounds of between 1 and 72 (median 5) households
within these communities were randomised to intervention
and control groups by water point (receiving/not receiving a pas-
sive chlorine-dosing device), stratified by site. Water points in
each site were ordered by the number of children <5 years old
residing in households accessing and using the enrolled water
points as their primary drinking-water source, then paired in
descending order to either treatment/control status via a random
number generator [23]. The parent study determined the eligibil-
ity of water points by the presence of a water storage tank com-
patible with the dosing device, and compounds had to have ≥1
child <5 years old using that water point as their primary source
of drinking water. Follow-up was discontinued if the child aged
out of the cohort or had migrated out of the study area and could
no longer be located. The study protocol was approved by the
scientific and ethical review boards of the International Centre
for Diarrheal Disease Research, Bangladesh (icddr,b, protocol
14022) and the human subjects institutional review board of
the Stanford University (protocol 30456) [23]. CDC coauthors
(Berendes) received de-identified data for analysis as per a non-
disclosure agreement with the Principal Investigator (Pickering).
Stool collection and analysis
Field staff collected whole stool specimens from all study children
during the sixth round of follow-up by instructing caregivers to
fill sterile plastic collection containers immediately after child
defecation. Field staff delivered collection kits to households and
attempted to retrieve the stool samples the following morning.
Field staff conducted up to three follow-up visits per household
to retrieve specimens. Specimens were kept at −80 °C at the
International Centre for Diarrheal Disease Research, Bangladesh
(icddr,b) in Dhaka, Bangladesh and transported on dry ice to
the Georgia Institute of Technology (Atlanta, GA, USA) where
they were stored at −80 °C until analysis.
We used the Luminex xTAG® Gastrointestinal Pathogen Panel
(GPP) to analyse the stool specimens. The GPP is a multiplex end-
point RT-PCR assay used to determine the presence or absence of
15 enteric pathogens: Campylobacter; Clostridium difficile, Toxin
A/B; E. coli O157; Enterotoxigenic E. coli (ETEC) LT/ST; Shiga-
like toxin-producing E. coli (STEC) stx1/stx2; Salmonella;
Shigella; Vibrio cholerae; Yersinia enterocolitica; adenovirus 40/41;
norovirus GI/GII; rotavirus A; Giardia; Cryptosporidium; and
Entamoeba histolytica. The GPP has been previously validated
against standard clinical assays for the detection of enteric patho-
gens in multiple countries with >90% sensitivity and ≥99% speci-
ficity across pathogens (e.g. [24]). We performed the GPP protocol
per manufacturer’s instructions: briefly, we pretreated specimens
with 1 mL of ASL stool lysis buffer (Qiagen, Hilden, Germany)
and co-extracted DNA and RNA using the QIAcube HT platform
and the QIAamp 96 Virus QIAcube HT Kit (Qiagen, Hilden,
Germany). We assayed 11% of samples in duplicate. Per GPP
protocol, all samples included an internal inhibition control
(MS2). Additionally, each assay run included at least one negative
extraction control (ASL buffer only), sample process control (ASL
buffer+MS2) and no-template PCR control. We analysed all
extracted DNA and RNA within 24 h of extraction. More detail
on methods can be also found in previously-described methods
of the Maputo Sanitation Trial [10].
2 David Berendes et al.
Anthropometry metrics
Pairs of trained anthropometrists measured the height and
weight of each child during the sixth round of follow-up, concur-
rent with stool specimen collection, using protocols from the
Anthropometric Indicators Measurement Guide by the Food
and Nutrition Technical Assistance (FANTA) project [25].
Anthropometrists measured child height (length) to the nearest
0.1 cm with a Seca Infant/Child ShorrBoard (Weigh and
Measure, LLC, Olney, MD, USA) and weight to the nearest
0.1 kg via a Seca 876 Mother/Baby scale (Weigh and Measure,
LLC). All heights and weights were measured in triplicate, with
the median used for analysis. We calculated height-for-age
Z-scores (HAZ scores), weight-for-age Z-scores (WAZ scores)
and weight-for-height Z-scores (WHZ scores) and associated
undernutrition outcomes (stunting, underweight and wasting,
respectively) using standard WHO criteria (below −2 standard
deviations (S.D.) for the associated indicator).
Survey data collection
We measured caregiver-reported diarrhoea within the previous
7 days in surveys concurrent to stool collection and anthropometric
measurements (round 6) using the locally-defined (‘caregiver-
defined’) definition of ‘patla paykana’ and the standard WHO def-
inition of ≥3 loose or watery stools in 24 h, with a visual cue [23].
At baseline and during each round of follow-up, field staff
administered surveys that collected information on household
demographics; water, sanitation and hygiene conditions; and
household socioeconomic status. Because some questions were
not included in each round of follow-up, we paired responses to
these survey questions with an enteric pathogen, anthropometry
and diarrhoea (all collected in round 6) by nearest prior round.
For example, if a question was administered in rounds 3 and 5,
we selected the response from round 5 in order to match the
results from round 6 most closely in time.
Statistical analysis
We assessed descriptive statistics, including pathogen carriage,
diarrhoea, anthropometry and demographic data by age: children
<2 years old (within the window where growth trajectories are set
[11, 26]) vs. children 2 to <5 years old. We used R version 3.4.3
(R Foundation for Statistical Computing, Vienna, Austria [27]),
with the lme4 package for (hierarchical) mixed-effects regression
modelling [28], for subsequent statistical analyses. We used
mixed-effects Poisson regression to estimate prevalence ratios
and associated confidence intervals for stunting, wasting and
underweight status, as well as caregiver-reported diarrhoea, by
the pathogen detected and included random effects for the com-
pound and household of the study child. We used mixed-effects
linear regression to estimate the differences in HAZ, WAZ and
WHZ by the pathogen detected and included the same random
effects. Consistent with the preregistered analysis plan of the par-
ent study, our adjusted analyses included a priori confounders
describing sociodemographic differences of the study child and
household, as well as the household’s placement in the rando-
mised-controlled trial. These factors included treatment group
in the parent study, reported water treatment at the household,
respondent’s highest level of education achieved, age and sex of
the child, and household income. For pathogens with significant
associations with nutritional outcomes in adjusted models, we
then compared the prevalence of pathogen detection between
children <2 vs. ≥2 years old. For pathogens with <5% prevalence,
we only ran unadjusted models to avoid problems with model
Table 1. Demographics of study children, Bangladesh, 2016 (n = 516)
Characteristic Mean (S.D.) or N (%)
Mother’s education
Beyond secondary school 37 (7.2%)
Completed secondary school 26 (5.0%)
Some secondary school 190 (37%)
Completed primary school 67 (13%)
Some primary school 147 (29%)
No formal school 49 (9.5%)
Income (BDTa) 17 118 (18 879)
Age of child (months) 31.9 (15.8)
Female child 253 (49%)
Number of people per room in household 3.5 (1.3)
Number of under-5 children per room in
household
0.9 (0.4)
Number of people in household 4.8 (1.8)





Tap in compound 498 (97%)
Tap in public location 17 (3.3%)
Tap in neighbour’s compound 1 (0.2%)
Any reported water treatment 88 (17%)
Any boiling 83 (16%)
Any use of ceramic filter 8 (1.6%)
Any use of cloth filter reported 38 (7.4%)
Intervention arm 244 (47%)
Toilet within compound
Flush/pour flush connected to tank or pit 497 (96%)
Flush/pour flush connected to sewer 8 (1.6%)
Pit latrine 7 (1.4%)
No toilet 4 (0.8%)
Number of households sharing toilet
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convergence. We used an α of 0.05 to determine statistical
significance.
Results
Demographics and health of study children
Of 1036 children enrolled in the trial at baseline, 57% were lost to
follow-up due to ageing out of the study (20%) or other reasons
(37%, e.g. moving out of the study compound); loss to follow-up
did not differ by intervention or control group [23]. The remaining
43% of children, combined with new enrolees in subsequent rounds,
yielded 516 children in round 6 from whom the stool specimens
were collected, tested for enteric pathogens and linked to other
demographic variables, diarrhoea and anthropometry outcomes.
Study households varied in income and education of the
respondent (generally the mother), and had between 2 and 13
people (mean 3.5) living in each room (Table 1). Study children
varied by age (range 12 days–60 months) and sex (49% female).
About 15% had siblings <5 years old. Most households obtained
their drinking water from a tap in their compound (97%). Few
(17%) reported treating their water despite approximately half
Table 2. Diarrhoea, enteric pathogens and malnutrition in study children in Bangladesh, 2016 (n = 516)
Mean (S.D.) or N (%)
Characteristic All <5 YO Children <2 YO Children 2–5 YO
Diarrhoea reported in last 7 days
Caregiver-defined 29 (5.6%) 13 (7.0%) 16 (4.8%)
WHO-defined 41 (7.9%) 20 (11%) 21 (6.4%)
Pathogens detected in stool
Giardia spp*** 204 (40%) 27 (15%) 177 (54%)
Salmonella enterica*** 170 (33%) 95 (51%) 75 (23%)
ETEC 143 (28%) 47 (25%) 96 (29%)
Shigella spp.*** 140 (27%) 28 (15%) 112 (34%)
Campylobacter spp. 101 (20%) 45 (24%) 56 (17%)
Norovirus 80 (16%) 33 (18%) 47 (14%)
E. coli o157 35 (6.8%) 8 (4.3%) 27 (8.2%)
STEC 29 (5.6%) 8 (4.3%) 21 (6.4%)
C. difficile 21 (4.1%) 13 (7.0%) 8 (2.4%)
Cryptosporidium 19 (3.7%) 12 (6.5%) 7 (2.1%)
Adenovirus 40/41 13 (2.5%) 12 (6.5%) 1 (0.3%)
Rotavirus 4 (0.8%) 3 (1.6%) 1 (0.3%)
E. histolytica 3 (0.6%) 0 3 (0.9%)
V. cholerae 1 (0.2%) 1 (0.5%) 0
Num. pathogens detected/child
0 61 (12%) 23 (12%) 38 (12%)
1 154 (30%) 56 (30%) 98 (30%)
2 159 (31%) 65 (35%) 94 (28%)
3 91 (18%) 25 (13%) 66 (20%)
4 39 (7.6%) 14 (8%) 25 (8%)
5 10 (1.9%) 3 (0.2%) 7 (2%)
6 2 (0.4%) 0 2 (0.6%)
HAZ (n = 481) −1.32 (1.11) −1.13 (1.08) −1.42 (1.11)
Stunted* 126 (26%) 33 (19%) 93 (30%)
WAZ (n = 513) −1.19 (1.06) −0.93 (1.02) −1.33 (1.06)
Underweight** 121 (24%) 30 (16%) 91 (28%)
WHZ (n = 487) −0.64 (1.08) −0.54 (1.14) −0.39 (5.72)
Wasted 36 (7.4%) 14 (8.0%) 22 (7.0%)
YO, year-olds.
*P < 0.05 for difference of proportions by age group; **P < 0.01 for difference of proportions by age group; ***P < 0.001 for difference of proportions by age group.
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of the participants (47%) being enrolled in the intervention arm,
which included no-cost chlorine treatment at the point-of-collec-
tion. Most of those who reported treating their drinking water
reported boiling (83/88). Most households had a pour-flush toilet
(98%), although >70% of households shared their toilet with at
least one other household and 30% shared with >5 households.
Few children (6%) had diarrhoea in the week preceding the inter-
view, as reported by their caregiver, but most (88%) had at least one
enteric pathogen in the stool specimen collected (Table 2). The most
frequently detected pathogens were Giardia spp. (40% prevalence),
Salmonella enterica (33%), enterotoxigenic E. coli (ETEC, 28%),
Shigella spp. (27%), Campylobacter spp. (20%) and norovirus
(16%). We detected Giardia spp. and Shigella spp. more often in
the specimens from older children (≥2 years old) compared with
younger children, while we detected S. enterica more often in the
stool of younger children. Mean HAZ (−1.32), WAZ (−1.19) and
WHZ (−0.64) were all negative, indicating many children were
undernourished. About 26% of children were stunted and 24%
were underweight, while 7% were wasted. Children ≥2 years old
were more likely to be stunted or underweight.
Associations between enteric pathogen detection and nutrition
outcomes
We compared enteric pathogens detected in the stool specimens
with concurrent undernutrition indicators in unadjusted models
and models adjusted for the study treatment group, age and sex
of the child, household income, any reported water treatment
and the respondent’s highest education attained (Tables 3 and 4).
Although children with Giardia spp. detected in the stool had
>50% increased prevalence of stunting and underweight in
unadjusted models, these relationships were elevated but not signifi-
cant in adjusted models (stunting PR 1.39, 95% CI 0.94–2.06;
underweight PR 1.23, 95% CI 0.83–1.83; Table 3). Children with
adenovirus 40/41 had more than three times higher prevalence of
wasting in unadjusted models, but could not be evaluated in
adjusted models due to the few (n = 13) detections
When examining HAZ, WAZ and WHZ scores continuously in
adjusted models, children with Giardia spp. had −0.22 S.D. lower
HAZ (95% CI −0.44 to 0.00) (Table 4). Although children with
Giardia spp. detected had lower WAZ while children with
Salmonella spp. detected had higher HAZ and WAZ in unadjusted
models, these relationships were attenuated in adjusted models.
In a subsequent analysis of Giardia spp. detection by age (chil-
dren <2 vs. ≥2 years old), Giardia spp. was more likely to be
detected in children ≥2 years old (Fig. 1): adjusted PR 3.67,
95% CI 2.43–5.52 (Table S1). In adjusted models, Shigella spp.
was also more likely to be detected in children ≥2 years old
(PR 2.19, 95% CI 1.44–3.34) while S. enterica (PR 0.42, 95% CI
0.31–0.58) and Campylobacter spp. (PR 0.64, 95% CI 0.43–0.95)
were less likely to be detected in ≥2 years old, as compared
with <2 years old (Table S1).
Associations between enteric pathogen detection and reported
diarrhoea
We compared enteric pathogen detection in the stool to
caregiver-defined and WHO-defined diarrhoea in the previous
week in both unadjusted and adjusted models using previously-
described covariates (Table 5). No pathogens were significantly
Table 3. Bivariable (unadjusted) and multivariable (adjusted) analyses of anthropometric outcome cut-offs by pathogen detection in the stool, Bangladesh, 2016














Giardia spp. 1.56 (1.10–2.21) 1.39 (0.94–2.06) 1.55 (1.09–2.22) 1.23 (0.83–1.83) 0.77 (0.39–1.55) 0.67 (0.32–1.44)
Salmonella
enterica
0.83 (0.56–1.21) 0.90 (0.60–1.35) 0.71 (0.47–1.06) 0.81 (0.53–1.24) 0.91 (0.45–1.84) 0.87 (0.42–1.82)
ETECb 0.98 (0.66–1.44) 0.93 (0.62–1.37) 1.14 (0.77–1.68) 1.08 (0.73–1.60) 1.43 (0.72–2.82) 1.38 (0.69–2.74)
Shigella spp. 1.05 (0.71–1.55) 0.90 (0.60–1.36) 1.11 (0.75–1.64) 0.90 (0.60–1.37) 1.06 (0.51–2.19) 0.97 (0.45–2.08)
Campylobacter
spp.
1.25 (0.83–1.89) 1.21 (0.79–1.87) 0.76 (0.47–1.24) 0.73 (0.44–1.21) 0.80 (0.33–1.93) 0.73 (0.30–1.79)
Norovirus 1.21 (0.77–1.90) 1.25 (0.79–1.98) 1.29 (0.82–2.03) 1.40 (0.89–2.23) 0.89 (0.34–2.28) 0.91 (0.35–2.35)
E. coli o157 0.80 (0.37–1.71) 0.83 (0.38–1.84) 0.97 (0.47–1.98) 0.94 (0.45–1.98) 0.38 (0.05–2.78) 0.32 (0.04–2.39)
STECc 1.03 (0.48–2.21) 0.86 (0.39–1.89) 1.18 (0.58–2.42) 1.09 (0.52–2.28) – –
C. difficile 0.84 (0.31–2.28) – 0.84 (0.31–2.28) – 2.24 (0.69–7.30) –
Cryptosporidium 1.13 (0.46–2.76) – 0.89 (0.33–2.41) – 1.53 (0.37–6.38) –
Adenovirus 40/41 – – 0.98 (0.31–3.08) – 3.31 (1.02–10.8) –
Rotavirus 1.27 (0.18–9.12) – 1.06 (0.15–7.59) – – –
E. histolytica 1.27 (0.18–9.12) – 1.42 (0.20–10.1) – 4.61 (0.63–33.6) –
V. cholerae – – – – – –
aAdjusted for treatment group, age (months), sex, income, reported water treatment and respondent’s highest education; ‘−’ indicates too few positive observations for stable model
convergence. As a rule, organisms with <5% prevalence were not analysed in multivariable (adjusted) associations. Bold indicates significant associations at P < 0.05.
bEnterotoxigenic E. coli.
cShiga-toxin-producing E. coli.
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Table 4. Bivariable (unadjusted) and multivariable (adjusted) analyses of continuous anthropometric outcomes by pathogen detection in the stool, Bangladesh, 2016
HAZ WAZ WHZ
Pathogen βstunting (95% CI) Adusted βstunting (95% CI)
a βunderwt (95% CI) Adjusted βunderwt (95% CI)
a βwasting (95% CI) Adjusted βwasting (95% CI)
a
Giardia spp. −0.36 (−0.56 to −0.16) −0.22 (−0.44 to 0.00) −0.39 (−0.58 to −0.21) −0.18 (−0.38 to 0.02) 0.35 (−0.49 to 1.19) 0.43 (−0.49 to 1.36)
Salmonella enterica 0.26 (0.05–0.47) 0.15 (−0.07 to 0.37) 0.33 (0.13–0.52) 0.18 (−0.02 to 0.39) −0.09 (−0.97, 0.79) −0.19 (−1.12 to 0.73)
ETECb −0.01 (−0.23 to 0.21) 0.03 (−0.19 to 0.25) −0.14 (−0.34 to 0.06) −0.08 (−0.28 to 0.12) −0.45 (−1.36 to 0.46) −0.50 (−1.43 to 0.42)
Shigella spp. 0.17 (−0.40 to 0.05) −0.04 (−0.27 to 0.19) −0.18 (−0.39 to 0.02) 0.03 (−0.18 to 0.24) 0.72 (−0.21 to 1.65) 0.82 (−0.15 to 1.79)
Campylobacter spp. −0.11 (−0.36 to 0.13) −0.16 (−0.41 to 0.09) −0.03 (−0.26 to 0.20) −0.07 (−0.30 to 0.16) −0.18 (−1.22 to 0.85) −0.45 (−1.50 to 0.61)
Norovirus −0.04 (−0.32 to 0.23) −0.08 (−0.35 to 0.20) 0.01 (−0.25 to 0.26) −0.05 (−0.30 to 0.20) −0.27 (−1.41 to 0.88) −0.35 (−1.50 to 0.81)
E. coli o157 −0.01 (−0.41 to 0.38) −0.01 (−0.41 to 0.38) −0.01 (−0.38 to 0.36) 0.03 (−0.33 to 0.40) −0.07 (−1.69 to 1.55) −0.44 (−2.09 to 1.21)
STECc −0.09 (−0.53 to 0.35) 0.00 (−0.43 to 0.44) −0.17 (−0.57 to 0.22) −0.14 (−0.53 to 0.25) −0.23 (−2.03 to 1.57) −0.28 (−2.12 to 1.56)
C. difficile 0.16 (−0.36 to 0.68) – 0.08 (−0.40 to 0.56) – −0.26 (−2.39 to 1.87) –
Cryptosporidium −0.25 (−0.79 to 0.29) – −0.23 (−0.71 to 0.26) – −0.15 (−2.34 to 2.03) –
Adenovirus 40/41 0.48 (−0.13 to 1.09) – 0.06 (−0.53 to 0.65) – −0.53 (−3.08 to 2.03) –
Rotavirus −0.23 (−1.49 to 1.03) – −0.34 (−1.38 to 0.70) – −0.67 (−5.94 to 4.59) –
E. histolytica 0.56 (−0.69 to 1.82) – 0.29 (−0.90 to 1.49) – −0.35 (−5.62 to 4.92) –
V. cholerae – – – – – –
aAdjusted for treatment group, age (months), sex, income, reported water treatment and respondent’s highest education; ‘-’ indicates too few positive observations for stable model convergence. As a rule, organisms with <5% prevalence were not










associated with diarrhoea, using either definition, in adjusted
models. In unadjusted models, adenovirus 40/41 detection was
significantly associated with caregiver-defined diarrhoea (PR
5.31, 95% CI 1.43–19.6) and rotavirus detection was significantly
associated with WHO-defined diarrhoea (PR 6.35, 95% CI 1.44–
28.0), though each were detected in very small proportions of
children’s stool (2.5% and 0.8%, respectively). Prevalence of
reported diarrhoea, using either definition, did not vary signifi-
cantly with the number of pathogens detected in the stool.
Discussion
This study assessed enteric pathogen carriage and nutritional out-
comes in a cross-section of children <5 years old enrolled in an exist-
ing trial cohort from urban Dhaka, Bangladesh [23]. We observed a
high prevalence of enteric pathogens detected in the stool (88%) des-
pite the low caregiver-reported prevalence of diarrhoea (6–8%,
depending on definition). Although rarely detected, viruses were
associated with caregiver-reported and/or WHO-defined diarrhoea,
but not other pathogens. Children with Giardia spp. detected in
the stool had significantly lower HAZ scores and were somewhat
more likely to be stunted (though this difference was not statistically
significant); howeverGiardia spp. detections were more likely in chil-
dren older than 24 months (outside the period when growth trajec-
tories may be altered [11, 26, 29]).
Our results contribute to the growing body of evidence that
exposure to or infection with enteric pathogen – as measured
by molecular assays of the stool – may be high despite the low
prevalence of reported diarrhoea. Similar results have been
found in other low-income, urban settings in children under 5
[10] and multisite studies of urban and rural settings focusing
on children in the first 2 years of life [9]. Taken together, these
findings represent a new challenge for implementers of changes
to environmental infrastructure and systems, such as WASH, to
mitigate enteric pathogen exposures (measured via the stool
detection of pathogens, a more sensitive metric) as contrasted
with previous studies of diarrhoea or clinical illness. However,
enteric pathogen detection may also be more useful as an out-
come in randomised-controlled trials given the higher prevalence
compared with diarrhoea [30, 31] and findings that reported diar-
rhoea may be associated with primarily viral pathogens (generally
not effectively mitigated by water and sanitation systems [10, 32]).
Thus, the use of caregiver-reported paediatric diarrhoea alone as
an outcome measure may be susceptible to biasing trial results
towards the null [32].
Our findings are consistent with other results suggesting
Giardia spp. as a highly prevalent, often asymptomatic pathogen
associated with growth faltering in children in low-income set-
tings [6, 8, 12, 33]. However, our evidence does not suggest that
Giardia spp. was a causative agent for child stunting, since
Giardia spp. was detected more often in children older than 2
years of age. Instead, our analysis suggests these already under-
nourished children may instead be more likely to be infected
with or unable to clear Giardia spp. infections, possibly due to
their malnutrition [34, 35], though we cannot characterise the dir-
ectionality of this association. Disproportionately higher rates of
Giardia spp. infections in older children may be explained by a
combination of weaning and increased mobility, both of which
increase potential exposure rates, since Giardia spp. infection is
rarely observed in very young, less-mobile, and often breastfed
Fig. 1. HAZ scores by age and Giardia spp. detection. Mean age and HAZ for children (n = 516) with and without Giardia spp. detection in the stool is denoted by
large blue triangles and red circles, respectively, with 95% confidence intervals for the X- and Y-axis means denoted by lines.
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in non-detects PRdiarrhoea (95% CI) aPRdiarrhoea (95% CI)
a
Caregiver-definedb Caregiver-definedb Caregiver-definedb Caregiver-definedb
WHO-definedc WHO-definedc WHO-definedc WHO-definedc
Giardia spp. 9/204 (4.4%) 20/312 (6.4%) 0.63 (0.28, 1.42) 0.82 (0.32, 2.13)
13/204 (6.4%) 28/312 (9.0%) 0.70 (0.36, 1.37) 0.86 (0.42, 1.76)
Salmonella enterica 12/170 (7.1%) 17/349 (4.9%) 1.45 (0.68, 3.09) 1.32 (0.59, 2.95)
14/170 (8.2%) 27/346 (7.8%) 1.05 (0.55, 2.01) 0.91 (0.46, 1.81)
ETECd 13/143 (9.1%) 16/373 (4.3%) 2.09 (0.98, 4.43) 2.05 (0.95, 4.43)
13/143 (9.1%) 28/373 (7.5%) 1.20 (0.62, 2.33) 1.09 (0.55, 2.15)
Shigella spp. 8/140 (5.7%) 21/376 (5.6%) 1.03 (0.44, 2.40) 1.28 (0.50, 3.28)
14/140 (10%) 27/376 (7.2%) 1.36 (0.71, 2.62) 1.78 (0.90, 3.53)
Campylobacter spp. 6/101 (5.9%) 23/415 (5.5%) 1.03 (0.41, 2.57) 0.76 (0.27, 2.16)
8/101 (7.9%) 33/415 (8.0%) 0.99 (0.45, 2.15) 0.68 (0.30, 1.56)
Norovirus 4/80 (5.0%) 25/436 (5.7%) 0.89 (0.30, 2.61) 0.77 (0.23, 2.54)
7/80 (8.8%) 34/436 (7.8%) 1.13 (0.50, 2.57) 0.97 (0.41, 2.29)
E. coli o157 1/35 (2.9%) 28/481 (5.8%) 0.57 (0.07, 4.54) 0.55 (0.06, 5.32)
2/35 (5.7%) 39/481 (8.1%) 0.73 (0.17, 3.08) 0.81 (0.19, 3.51)
STECe 0/29 (0.0%) 29/487 (6.0%) – –
1/29 (3.4%) 40/487 (8.2%)
C. difficile 2/21 (9.5%) 27/495 (5.5%) 2.34 (0.50, 10.9) –
1/21 (4.8%) 40/495 (8.1%) 0.63 (0.08, 4.62)
Cryptosporidium 3/19 (16%) 26/497 (5.2%) 2.51 (0.70, 8.97) –
2/19 (11%) 39/497 (7.8%) 1.35 (0.32, 5.66)
Adenovirus 40/41 3/13 (23%) 26/503 (5.2%) 5.31 (1.43, 19.6) –
3/13 (23%) 38/503 (7.6%) 3.04 (0.90, 10.2)
Rotavirus 1/4 (25%) 28/512 (5.5%) 3.57 (0.43, 29.7) –
2/4 (50%) 39/512 (7.6%) 6.35 (1.44, 28.0)
E. histolytica 0/3 (0.0%) 29/513 (5.7%) – –
0/3 (0.0%) 41/513 (8.0%)
V. cholera 1/1 (100%) 28/515 (5.4%) – –
1/1 (100%) 40/515 (7.8%)
None detected 4/61 (6.6%) 25/455 (5.5%) – –
5/61 (8.2%) 36/455 (7.9%)
Number of detects
Continuous 1.27 (0.91, 1.78) 1.18 (0.87, 1.59)
1.08 (0.83, 1.41) 1.05 (0.82, 1.35)
Any co-detection 20/301 (6.6%) 1.05 (0.34, 3.26) 1.04 (0.32, 3.45)
26/301 (8.6%) 1.07 (0.41, 2.82) 1.10 (0.42, 2.94)
Single detection 5/154 (3.2%) 0.46 (0.12, 1.75) 0.50 (0.11, 2.19)
10/154 (6.5%) 0.80 (0.27, 2.35) 0.88 (0.29, 2.64)
No detection 4/61 (6.6%) Ref. Ref.
5/61 (8.2%) Ref. Ref.
aAdjusted for treatment group, age (months), water treatment, sex, income and respondent’s highest education.
bn = 29 reported.
cn = 41 reported.
dEnterotoxigenic E. coli.
eShiga-toxin-producing E. coli. ‘−’ indicates too few positive observations for stable model convergence. As a rule, organisms with <5% prevalence were not analysed in multivariable
(adjusted) associations. Bold indicates significant associations at P < 0.05.
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infants and infection rates increase with age [33]. Alternatively,
one may hypothesise that children in our study had ‘chronic’
Giardia spp. infections (>6 months in some cases [36]) resulting
in ongoing shedding due to previous or repeat asymptomatic
infections and been unlikely to receive anti-protozoal drugs due
to the absence of symptoms.
In contrast to our findings, evidence from other studies still
strongly supports Giardia spp. as a key infection that drives
reduced growth in young children worldwide, though with
mixed evidence on the mechanism of action (e.g. inflammatory
pathways, increased gut permeability or other morphological
changes characteristic of EED [5]). Longitudinal data
from the Etiology, Risk Factors, and Interactions of Enteric
Infections and Malnutrition and Consequences for Child
Health and Development Project (MAL-ED study) indicated
Giardia spp. infection in the first 6 months of life was asso-
ciated with decreased HAZ at 24 months of age [4, 33].
Mouse models have shown persistent Giardia spp. infection
to be associated with increased inflammatory response, changes
to gut villi structure and poorer growth [37], and there is
evidence that adults in high-income settings have experienced
changes to gut morphology following a Giardia spp.
outbreak [36].
There are important limitations to consider in this analysis.
Although enteric infections may be persistent in young children,
the stool specimens were analysed using molecular detection
methods that detected the presence/absence at a single surveil-
lance point; intermittently shed pathogens may be missed in a
single stool analysis, which could have been avoided if multiple
stool specimens were analysed. Among those specimens with
positive detects, we cannot identify whether and when a clinical
infection was present (and/or duration), including its intensity,
or whether shedding of a pathogen was due to other causes
[38]. Additionally, although WASH conditions were consistent
within the study population and we adjusted for water treatment,
income and respondent’s education among other potential con-
founders, other environmental, socioeconomic and nutritional
variables that we did not measure could have impacted pathways
we assessed. We matched survey data to stool collections as closely
as possible in time with outcome ascertainment; however,
assumptions about the temporal stability of environmental condi-
tions and sociodemographic characteristics (e.g. consistent condi-
tions across time) were necessary that could have affected the
exposure–infection relationships. Cross-sectional analyses have
strict temporal constraints and directionality of association cannot
be directly assessed.
Enteric infections, as detected via pathogen carriage in the
stool, are highly prevalent in low-income children despite the
low concurrent prevalence of reported diarrhoea. Giardia spp. is
the most common parasitic infection in young children in
many low-income settings and is generally not associated with
clinical diarrhoea, but is associated with growth faltering.
Results from this analysis contribute to the growing literature sur-
rounding associations between Giardia spp. infections and mal-
nutrition and linear growth in these settings [6, 33, 36, 37, 39,
40], yet may suggest Giardia spp. infections as a symptom, rather
than a cause, of undernutrition. Because Giardia and other enteric
pathogens detected in the stool are unambiguous markers of past
exposure and because they are on the causal pathway to infection,
disease and longer-term health outcomes, such targets may offer
potential advantages as outcomes in trials of environmental
improvement (e.g. WASH) interventions.
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be found at https://doi.org/10.1017/S0950268820000369
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